ライフサイエンスコーパス: leg pain

1 te or chronic low back pain (with or without leg pain).

2 often a challenging option for patients with leg pain.

3 extremities and are a rare cause of chronic leg pain.

4 long duration of LBP episodes, and radiating leg pain.

5 e patients present with non-specific chronic leg pain.

6 eported LBP only and 21.3% reported LBP plus leg pain.

7 the low back or leg, LBP only, and LBP with leg pain.

8 es were independent correlates of exertional leg pain.

9 ere all significant correlates of exertional leg pain.

10 audication Questionnaire assessed exertional leg pain.

11 ercent of PAD participants had no exertional leg pain.

12 I], -2.1 to 0.1; P=0.07) or the intensity of leg pain (adjusted difference in the average treatment e

13 adaches but more difficulty with walking and leg pain (all p < 0.05).

14 d injections offer only short-term relief of leg pain and disability for patients with sciatica.

15 ntral spinal stenosis and moderate-to-severe leg pain and disability to receive epidural injections o

16 Nine female patients with leg pain and imaging features indicative of intramedulla

17 ral corticosteroid injections are useful for leg pain and sensory deficits early in the course of sci

18 y healthy 41-year-old man presents with left leg pain and shortness of breath.

19 6 months or later using Ginsberg's criteria (leg pain and swelling of >/=1 month duration).

20 erential diagnosis in a patient with chronic leg pain and swelling.

21 ineteen patients with activity-related lower leg pain and tenderness on palpation along the posterome

22 ld man presented with progressive asymmetric leg pain and weakness.

23 was to determine whether LBP and concurrent leg pain are associated with health-related quality of l

24 id not significantly reduce the intensity of leg pain associated with sciatica and did not significan

25 Leg pain, back pain, and disability were converted to co

26 Back-related leg pain (BRLP) is often disabling and costly, and there

27 th IC, participants with atypical exertional leg pain/carry on achieved a greater distance on the 6-m

28 The atypical exertional leg pain/carry on group (exertional leg pain other than

29 2% of children had early symptoms of sepsis (leg pains, cold hands and feet, abnormal skin colour) th

30 The tool included 9 items: referred leg pain, comorbid pain, disability (2 items), bothersom

31 oes not develop the symptoms of back pain or leg pain during the injection.

32 articipants who never experienced exertional leg pain, even during the 6-minute walk; n=72).

33 Participants with LBP and LBP plus leg pain had lower scores in all SF-36 domains, reflecti

34 exertional leg pain/inactive (no exertional leg pain in individual who walks </=6 blocks per week [n

35 steroid injections compared with placebo for leg pain in the short term (mean difference, -6.2 [95% C

36 The group without exertional leg pain/inactive (no exertional leg pain in individual

37 The differential diagnosis of exertional leg pain includes stress fractures, stress reaction, per

38 The primary outcome was the leg-pain intensity score on a 10-point scale (with 0 ind

39 At week 52, the mean unadjusted leg-pain intensity score was 3.4 in the pregabalin group

40 At week 8, the mean unadjusted leg-pain intensity score was 3.7 in the pregabalin group

41 d 10 the worst possible pain) at week 8; the leg-pain intensity score was also evaluated at week 52,

42 Although exertional leg pain is a hallmark of peripheral arterial disease (P

43 Among participants without exertional leg pain, lower ABI levels were associated with slower w

44 1-9.9), the presence of bilateral buttock or leg pain (LR, 6.3; 95% CI, 3.1-13), and neurogenic claud

45 ther than IC associated with walking through leg pain [n = 41]) and the atypical exertional leg pain/

46 uppression, fatigue, neurotoxicity, rash, or leg pain) necessitating dose reduction (n = 4) or discon

47 ude the chest pain of a heart attack and the leg pain of a 30 s sprint--occurs when muscle gets too l

48 Participants in the group with leg pain on exertion and rest (n = 88) had a higher (poo

49 ticipants without PAD, PAD participants with leg pain on exertion and rest at baseline had greater me

50 walks </=6 blocks per week [n = 28]) and the leg pain on exertion and rest group had poorer functioni

51 sability) and the rating of the intensity of leg pain (on a scale from 0 to 10, with 0 indicating no

52 ertional leg pain/carry on group (exertional leg pain other than IC associated with walking through l

53 l exertional leg pain/stop group (exertional leg pain other than IC that causes one to stop walking [

54 arthritis, diabetes mellitus, stroke, upper leg pain, peripheral vascular disease, left ventricular

55 PRIMARY OUTCOME: back or leg pain-related disability measured by the modified Rol

56 dural steroids (75%) reported 50% or greater leg pain relief and a positive global perceived effect a

57 For leg pain, SMT plus HEA had a clinically important advant

58 g pain [n = 41]) and the atypical exertional leg pain/stop group (exertional leg pain other than IC t

59 The main clinical feature is recurrent leg pain that progresses to constant painful paraesthesi

60 te or chronic low back pain (with or without leg pain) that reported pain outcomes, back-specific fun

61 d high-normal ABIs appeared to have ischemic leg pain; thus, a "normal ABI" is likely to range from 1

62 age, sex, body mass index, absence of whole leg pain, traumatic onset, difficulty descending stairs,

63 LBP plus leg pain was associated with difficulty in social intera

64 No category of exertional leg pain was sufficiently sensitive or specific for rout

65 LBP and LBP plus leg pain were associated with 2-fold greater odds of fal